Amy Ma

Product Manager at ALL Chemistry Inc.

United States · MarltonJoined January 2023


ALL Chemistry Inc. is your reliable partner for contract research and advanced synthesis and analysis. We specialize in providing professional chemical products and custom solutions for pharmaceutical and biotechnological industries and research institutions on a global scale. Our extensive catalog of research chemicals covers chiral compounds, natural compounds, labeled products, small molecule inhibitors, flavor and fragrance products, and we offer custom synthesis, custom compound screening and library services upon customer requirements. Headquartered in Marlton, NJ, the team of ALL Chemistry Inc. has strong global delivery network and professional technical support to meet diversity needs from worldwide customers.

ALL Chemistry has a strong background in custom synthesis, custom compound screening and other related services. We are an integrated service provider with expertise and rich experience in the following areas:

- Custom Synthesis
- Asymmetric Synthesis
- Bioorganic Chemistry
- Stable Isotope Labeling
- Compound Screening Services
- Custom Compound Library

Our Mission

At ALL Chemistry, our mission is to offer a wide range of high-valued chemical products and services to help customers accelerate their research process and reach more productive and successful goals. With our expertise, we strive to provide flexible and adaptable solutions for our clients by allowing them to focus on their business and enjoy most satisfying experience. Our ultimate goal is to build long-lasting collaborative relationships with our clients.

Our Values
- Customer-focused
- Commitment and Responsibility
- Professional and Knowledgeable
- Innovative
- Passion to keep improving

Research areas of interest (5)

  • Biological Sciences
  • Biology / Biotechnology
  • Synthetic Biology
  • Industrial Products
  • Chemicals and Materials

Amy Ma didn't publish any Technology Call yet

Desloratadine is a histamine H1-receptor antagonist that the FDA approved as a treatment for the relief of seasonal allergic rhinitis in patients 12 years or older.[…]

Amy Ma didn't publish any Paper yet

Amy Ma didn't publish any Event yet

Amy Ma didn't publish any Job yet

Amy Ma didn't publish any New and Article yet

Amy Ma didn't publish any Education Resource yet

You are signed out

Join Innoget to connect with Amy Ma and thousands
of innovation-driven professionals and organizations